Table 1

Characteristics of patients studied

HMG CoA, 3-hydroxy-3-methylglutaryl coenzyme A.
*Mean (SD)
Number of patients87
Age (years) (range)75 (51–93)
Sex (male/female)51/36
Current angina38
Previous myocardial infarction40
Diabetes13
Chronic obstructive pulmonary disease24
Atrial fibrillation25
β Blocker9
Angiotensin converting enzyme inhibitor37
Diuretic60
HMG CoA reductase inhibitor2
Calcium channel blocker20
Digoxin17
Nitrate12
Aspirin43
Warfarin9
Admission New York Heart Association class
    II21
    III28
    IV38
Creatinine (μmol/l)*132 (7.2)